3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Personalized therapy for Helicobacter pylori: CYP2C19 genotype effect on first-line triple therapy.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Triple therapy efficacy against Helicobacter pylori is low worldwide, and thus, alternatives must be sought to improve eradication. The aim of the present study was to determine CYP2C19 genetic polymorphism effect on H pylori eradication.

          Related collections

          Author and article information

          Journal
          Helicobacter
          Helicobacter
          Wiley
          1523-5378
          1083-4389
          Jun 2019
          : 24
          : 3
          Affiliations
          [1 ] Laboratorio de Bacteriología Especial, Grupo de Enfermedades Infecciosas, Departamento de Microbiología, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogotá, Colombia.
          [2 ] Unidad de Gastroenterología, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia.
          [3 ] Unidad de Gastroenterología Clínica Fundadores, Bogotá, Colombia.
          Article
          10.1111/hel.12574
          30859680
          e64cc0b1-373c-4d37-bcf5-da1bcac61a4a
          History

          CYP2C19 , H pylori ,personalized therapy
          CYP2C19 , H pylori , personalized therapy

          Comments

          Comment on this article